首页> 美国卫生研究院文献>Frontiers in Genetics >Quantum Dot Based Nano-Biosensors for Detection of Circulating Cell Free miRNAs in Lung Carcinogenesis: From Biology to Clinical Translation
【2h】

Quantum Dot Based Nano-Biosensors for Detection of Circulating Cell Free miRNAs in Lung Carcinogenesis: From Biology to Clinical Translation

机译:基于量子点的纳米生物传感器用于检测肺癌致癌性中循环性游离细胞的miRNA:从生物学到临床翻译

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lung cancer is the most frequently occurring malignancy and the leading cause of cancer-related death for men in our country. The only recommended screening method is clinic based low-dose computed tomography (also called a low-dose CT scan, or LDCT). However, the effect of LDCT on overall mortality observed in lung cancer patients is not statistically significant. Over-diagnosis, excessive cost, risks associated with radiation exposure, false positive results and delay in the commencement of the treatment procedure questions the use of LDCT as a reliable technique for population-based screening. Therefore, identification of minimal-invasive biomarkers able to detect malignancies at an early stage might be useful to reduce the disease burden. Circulating nucleic acids are emerging as important source of information for several chronic pathologies including lung cancer. Of these, circulating cell free miRNAs are reported to be closely associated with the clinical outcome of lung cancer patients. Smaller size, sequence homology between species, low concentration and stability are some of the major challenges involved in characterization and specific detection of miRNAs. To circumvent these problems, synthesis of a quantum dot based nano-biosensor might assist in sensitive, specific and cost-effective detection of differentially regulated miRNAs. The wide excitation and narrow emission spectra of these nanoparticles result in excellent fluorescent quantum yields with a broader color spectrum which make them ideal bio-entities for fluorescence resonance energy transfer (FRET) based detection for sequential or simultaneous study of multiple targets. In addition, photo-resistance and higher stability of these nanoparticles allows extensive exposure and offer state-of-the art sensitivity for miRNA targeting. A major obstacle for integrating QDs into clinical application is the QD-associated toxicity. However, the use of non-toxic shells along with surface modification not only overcomes the toxicity issues, but also increases the ability of QDs to quickly detect circulating cell free miRNAs in a non-invasive mode. The present review illustrates the importance of circulating miRNAs in lung cancer diagnosis and highlights the translational prospects of developing QD-based nano-biosensor for rapid early disease detection.
机译:肺癌是最常见的恶性肿瘤,是我国男性与癌症相关的死亡的主要原因。唯一推荐的筛查方法是基于临床的低剂量计算机断层扫描(也称为低剂量CT扫描或LDCT)。但是,LDCT对肺癌患者总死亡率的影响在统计学上并不显着。过度诊断,过高的成本,与放射线接触相关的风险,假阳性结果以及治疗程序开始延迟,这对将LDCT用作基于人群的可靠筛查技术提出了质疑。因此,鉴定能够在早期阶段检测恶性肿瘤的微创生物标志物可能有助于减轻疾病负担。循环核酸正在成为包括肺癌在内的几种慢性疾病的重要信息来源。其中,循环中的无细胞miRNA据报道与肺癌患者的临床结果密切相关。较小的大小,物种之间的序列同源性,低浓度和稳定性是miRNA表征和特异性检测涉及的一些主要挑战。为了避免这些问题,基于量子点的纳米生物传感器的合成可能有助于灵敏,特异性和成本有效地检测差异调节的miRNA。这些纳米粒子的宽激发和窄发射光谱可产生出色的荧光量子产率,并具有较宽的色谱光谱,这使其成为基于荧光共振能量转移(FRET)的检测的理想生物实体,可用于顺序或同时研究多个目标。另外,这些纳米颗粒的光阻和更高的稳定性允许广泛的曝光,并提供针对miRNA靶向的最新技术。将QD纳入临床应用的主要障碍是与QD相关的毒性。但是,使用无毒外壳和表面修饰不仅克服了毒性问题,而且还提高了QD以无创方式快速检测循环中的无细胞miRNA的能力。本综述说明了循环miRNA在肺癌诊断中的重要性,并强调了开发基于QD的纳米生物传感器用于早期疾病早期检测的翻译前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号